Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyponidd is a proprietary Ayurvedic herbal formulation developed and manufactured by Charak Pharma. It is designed to support metabolic wellness and reproductive health, primarily serving as an herbal insulin sensitizer. Hyponidd is commonly used in the management of type 2 diabetes mellitus and polycystic ovary syndrome (PCOS). The formulation contains a synergistic blend of traditional Ayurvedic herbs and minerals, including Vijaysaar (*Pterocarpus marsupium*), Haridra (*Curcuma longa*), Karela (*Momordica charantia*), Gudmar (*Gymnema sylvestre*), Amalaki (*Emblica officinalis*), and Guduchi (*Tinospora cordifolia*). These ingredients work together to improve insulin sensitivity, regulate glucose metabolism, reduce oxidative stress, and support hormonal balance and ovulation in women with PCOS.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyponidd.